Back
Sarepta Therapeutics Vs. Lemonade Industry Stock Comparison
Sell
42
SRPT
Sarepta Therapeutics
Last Price:
$121.53
Seasonality Move:
9.24%
Sell
31
LMND
Lemonade
Last Price:
$36.71
Seasonality Move:
-12.12%
Sell
42
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $121.59. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Lemonade (LMND)
is a Sell
Is Lemonade a Buy, Sell or Hold?
-
LMND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $121.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
LMND Stock Price Chart
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 47.98 | Sell |
| Chaikin Money Flow: | 14371 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.06 - 129.7) | Sell |
| Bollinger Bands (100): | (117.97 - 133.69) | Sell |
LMND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 43.63 | Sell |
| Chaikin Money Flow: | -1447930 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.47 - 47.59) | Sell |
| Bollinger Bands (100): | (14.82 - 38.7) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.08 | Buy |
| 20-day SMA: | 123.89 | Sell |
| 50-day SMA: | 122.63 | Sell |
| 200-day SMA: | 129.62 | Sell |
| 8-day EMA: | 121.85 | Sell |
| 20-day EMA: | 122.51 | Sell |
| 50-day EMA: | 123.28 | Sell |
| 200-day EMA: | 125.75 | Sell |
LMND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.92 | Sell |
| 20-day SMA: | 42.02 | Sell |
| 50-day SMA: | 36.05 | Buy |
| 200-day SMA: | 22.08 | Buy |
| 8-day EMA: | 39.73 | Sell |
| 20-day EMA: | 40.72 | Sell |
| 50-day EMA: | 36.55 | Buy |
| 200-day EMA: | 25.13 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.84 per share, and an increase next year of $4.82 per share.
Lemonade Earnings Growth & LMND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $1.36 per share.
Sarepta Therapeutics Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lemonade Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||